BIXT
BIOXYTRAN, INC
Key Financials
Gross Profit
$87098
↓ 42.0%
Revenue
$191077
↓ 22.5%
Operating Income
$-1842509
↑ 17.1%
EPS (Diluted)
$-0.02
0.0%
Total Liabilities
$3.2M
↑ 68.3%
Net Income
$-2123077
↑ 10.3%
Total Assets
$658552.00
↑ 374.8%
Cash & Equivalents
$11092.00
↑ 218.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 4/15/2026 | View on SEC |
| NT 10-K | 4/1/2026 | View on SEC |
| 8-K | 3/20/2026 | View on SEC |
| 8-K | 3/13/2026 | View on SEC |
| 8-K | 3/2/2026 | View on SEC |
| 8-K | 2/17/2026 | View on SEC |
| 8-K | 2/11/2026 | View on SEC |
| 8-K | 1/5/2026 | View on SEC |
| 8-K | 12/15/2025 | View on SEC |
| 4 | 11/18/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BIXT |
| Company Name | BIOXYTRAN, INC |
| CIK | 1445815 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 617-494-1199 |